» Articles » PMID: 30425194

Beneficial Effect of Moderately Increasing Hypothermic Machine Perfusion Pressure on Donor After Cardiac Death Renal Transplantation

Overview
Specialty General Medicine
Date 2018 Nov 15
PMID 30425194
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular resistance and flow rate during hypothermic machine perfusion (HMP) of kidneys is correlated with graft function. We aimed to determine the effects of increasing HMP pressure versus maintaining the initial pressure on kidney transplantation outcomes.

Methods: We retrospectively reviewed the data of 76 primary transplantation patients who received HMP-preserved kidneys from 48 donors after cardiac death between September 1, 2013, and August 31, 2015. HMP pressure was increased from 30 to 40 mmHg (1 mmHg = 0.133 kPa) in kidneys with poor flow and/or vascular resistance (increased pressure [IP] group; 36 patients); otherwise, the initial pressure was maintained (constant pressure group; 40 patients). Finally, the clinical characteristics and transplantation outcomes in both groups were assessed.

Results: Delayed graft function (DGF) incidence, 1-year allograft, patient survival, kidney function recovery time, and serum creatinine level on day 30 were similar in both groups, with improved flow and resistance in the IP group. Among patients with DGF, kidney function recovery time and DGF duration were ameliorated in the IP group. Multivariate logistic regression analysis revealed that donor hypertension (odds ratio [OR]: 1.43, 95% confidence interval [CI]: 1.02-2.06, P = 0.035), donor terminal serum creatinine (OR: 1.27, 95% CI: 1.06-1.62, P = 0.023), warm ischemic time (OR: 3.45, 95% CI: 1.97-6.37, P = 0.002), and terminal resistance (OR: 3.12, 95% CI: 1.76-6.09, P = 0.012) were independent predictors of DGF. Cox proportional hazards analysis showed that terminal resistance (hazard ratio: 2.06, 95% CI: 1.32-5.16, P = 0.032) significantly affected graft survival.

Conclusion: Increased HMP pressure improves graft perfusion but does not affect DGF incidence or 1-year graft survival.

Citing Articles

Clinical outcomes prediction in kidney transplantation by use of biomarkers from hypothermic machine perfusion.

Leite R, Leite Jr M, Einicker-Lamas M, Valverde R, Miranda L, Schanaider A Int Braz J Urol. 2024; 50(4):470-479.

PMID: 38743065 PMC: 11262724. DOI: 10.1590/S1677-5538.IBJU.2024.0166.


Outcomes of Kidney Perfusion Techniques in Transplantation from Deceased Donors: A Systematic Review and Meta-Analysis.

Ghoneima A, Sousa Da Silva R, Gosteli M, Barlow A, Kron P J Clin Med. 2023; 12(12).

PMID: 37373568 PMC: 10298857. DOI: 10.3390/jcm12123871.


The role of hypothermic machine perfusion in selecting renal grafts with advanced histological score.

Ruberto F, Lai Q, Piazzolla M, Brisciani M, Pretagostini R, Garofalo M Artif Organs. 2022; 46(9):1771-1782.

PMID: 35548925 PMC: 9544822. DOI: 10.1111/aor.14308.


Perioperative risk factors associated with delayed graft function following deceased donor kidney transplantation: A retrospective, single center study.

Mendez N, Raveh Y, Livingstone J, Ciancio G, Guerra G, Burke Iii G World J Transplant. 2021; 11(4):114-128.

PMID: 33954089 PMC: 8058644. DOI: 10.5500/wjt.v11.i4.114.


Predictors and one-year outcomes of patients with delayed graft function after deceased donor kidney transplantation.

Chen R, Wang H, Song L, Hou J, Peng J, Dai H BMC Nephrol. 2020; 21(1):526.

PMID: 33276737 PMC: 7716446. DOI: 10.1186/s12882-020-02181-1.


References
1.
Moers C, Pirenne J, Paul A, Ploeg R . Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2012; 366(8):770-1. DOI: 10.1056/NEJMc1111038. View

2.
Mozes M, Skolek R, Korf B . Use of perfusion parameters in predicting outcomes of machine-preserved kidneys. Transplant Proc. 2005; 37(1):350-1. DOI: 10.1016/j.transproceed.2005.01.058. View

3.
Doorschodt B, Schreinemachers M, Behbahani M, Florquin S, Weis J, Staat M . Hypothermic machine perfusion of kidney grafts: which pressure is preferred?. Ann Biomed Eng. 2010; 39(3):1051-9. DOI: 10.1007/s10439-010-0228-7. View

4.
Heilman R, Mathur A, Smith M, Kaplan B, Reddy K . Increasing the Use of Kidneys From Unconventional and High-Risk Deceased Donors. Am J Transplant. 2016; 16(11):3086-3092. DOI: 10.1111/ajt.13867. View

5.
Vaziri N, Thuillier R, Favreau F, Eugene M, Milin S, Chatauret N . Analysis of machine perfusion benefits in kidney grafts: a preclinical study. J Transl Med. 2011; 9:15. PMC: 3038164. DOI: 10.1186/1479-5876-9-15. View